Plain-English translation of NCT06714344 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a computer tool called the Assisted Therapy Optimizing Module (AMPEL) that helps doctors follow treatment guidelines more closely when caring for heart failure patients. Some doctors will have access to this tool while others won't, so researchers can see whether it helps improve treatment quality and patient outcomes. The study involves about 234 people with heart failure across multiple medical centers.
Many doctors aren't prescribing heart failure medications according to the latest medical guidelines, even though these treatments are proven to help people feel better and avoid hospitalization. This trial wants to see if giving doctors a computer tool that guides them through best-practice treatment decisions can close that gap and lead to better care.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either receive care with the new computer tool or standard care without it. Your doctor will use whichever system you're assigned to help manage your heart failure treatment going forward. You'll continue regular follow-up visits as part of your heart failure care, and researchers will track your health outcomes and medication use over time to see if the tool made a difference.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Austria
Sponsor
Medical University Innsbruck
Collaborators
AIT Austrian Institute of Technology GmbH
Enrollment target
~234 participants
Started
December 2024
Primary completion
September 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Gerhard Poelzl, Prof. Dr.
Medical University Innsbruck
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.